Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.23.5 (
cathepsin D
)
4,130
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have recently identified the
hADA3
protein, the human homologue of yeast transcriptional coactivator yADA3, as a novel HPV16 E6 target. Using ectopic expression approaches, we further demonstrated that
hADA3
directly binds to the 9-cis retinoic acid receptors alpha and beta, and functions as a coactivator for retinoid receptor-mediated transcriptional activation. Here, we examined the role of endogenous
hADA3
as a coactivator for estrogen receptor (ER), an important member of the nuclear hormone receptor superfamily. We show that
ADA3
directly interacts with ER alpha and ER beta. Using the chromatin immunoprecipitation assay, we also show that
hADA3
is a component of the activator complexes bound to the native ER response element within the promoter of the estrogen-responsive gene pS2. Furthermore, using an ER response element-luciferase reporter, we show that overexpression of
ADA3
enhances the ER alpha- and ER beta-mediated sequence-specific transactivation. Reverse transcription-PCR analysis showed an
ADA3
-mediated increase in estrogen-induced expression of the endogenous pS2 gene. More importantly, using RNA interference against
hADA3
, we demonstrate that inhibition of endogenous
hADA3
inhibited ER-mediated transactivation and the estrogen-induced increase in the expression of pS2,
cathepsin D
, and progesterone receptor, three widely known ER-responsive genes. The HPV E6 protein, by targeting
hADA3
for degradation, inhibited the ER alpha-mediated transactivation and the protein expression of ER target genes. Thus, our results demonstrate that
ADA3
directly binds to human estrogen receptor and enhances the transcription of ER-responsive genes, suggesting a broader role of mammalian
hADA3
as a coactivator of nuclear hormone receptors and the potential role of these pathways in HPV oncogenesis.
...
PMID:Human ADA3 binds to estrogen receptor (ER) and functions as a coactivator for ER-mediated transactivation. 1549 19